Cargando…

On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations

Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids have been demonstrated to be promising agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Raquel, Costa Lima, Sofia A., Gameiro, Paula, Reis, Salette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472229/
https://www.ncbi.nlm.nih.gov/pubmed/34573007
http://dx.doi.org/10.3390/antiox10091376
_version_ 1784574675306676224
author Costa, Raquel
Costa Lima, Sofia A.
Gameiro, Paula
Reis, Salette
author_facet Costa, Raquel
Costa Lima, Sofia A.
Gameiro, Paula
Reis, Salette
author_sort Costa, Raquel
collection PubMed
description Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids have been demonstrated to be promising agents in the treatment of several skin disorders. However, their lipophilic nature and poor water solubility invariably lead to limited oral bioavailability. In addition, they are rapidly degraded and metabolized in the human body, hindering their potential contribution to the prevention and treatment of many disorders. Thus, to overcome these challenges, several cutaneous delivery systems have been extensively studied. Topical drug delivery besides offering an alternative administration route also ensures a sustained release of the active compound at the desired site of action. Incorporation into lipid or polymer-based nanoparticles appears to be a highly effective approach for cutaneous delivery of flavonoids with good encapsulation potential and reduced toxicity. This review focuses on currently available formulations used to administer either topically or systemically different classes of flavonoids in the skin, highlighting their potential application as therapeutic and preventive agents.
format Online
Article
Text
id pubmed-8472229
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84722292021-09-28 On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations Costa, Raquel Costa Lima, Sofia A. Gameiro, Paula Reis, Salette Antioxidants (Basel) Review Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids have been demonstrated to be promising agents in the treatment of several skin disorders. However, their lipophilic nature and poor water solubility invariably lead to limited oral bioavailability. In addition, they are rapidly degraded and metabolized in the human body, hindering their potential contribution to the prevention and treatment of many disorders. Thus, to overcome these challenges, several cutaneous delivery systems have been extensively studied. Topical drug delivery besides offering an alternative administration route also ensures a sustained release of the active compound at the desired site of action. Incorporation into lipid or polymer-based nanoparticles appears to be a highly effective approach for cutaneous delivery of flavonoids with good encapsulation potential and reduced toxicity. This review focuses on currently available formulations used to administer either topically or systemically different classes of flavonoids in the skin, highlighting their potential application as therapeutic and preventive agents. MDPI 2021-08-28 /pmc/articles/PMC8472229/ /pubmed/34573007 http://dx.doi.org/10.3390/antiox10091376 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Costa, Raquel
Costa Lima, Sofia A.
Gameiro, Paula
Reis, Salette
On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title_full On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title_fullStr On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title_full_unstemmed On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title_short On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations
title_sort on the development of a cutaneous flavonoid delivery system: advances and limitations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472229/
https://www.ncbi.nlm.nih.gov/pubmed/34573007
http://dx.doi.org/10.3390/antiox10091376
work_keys_str_mv AT costaraquel onthedevelopmentofacutaneousflavonoiddeliverysystemadvancesandlimitations
AT costalimasofiaa onthedevelopmentofacutaneousflavonoiddeliverysystemadvancesandlimitations
AT gameiropaula onthedevelopmentofacutaneousflavonoiddeliverysystemadvancesandlimitations
AT reissalette onthedevelopmentofacutaneousflavonoiddeliverysystemadvancesandlimitations